Gerresheimer AG (ETR:GXI)

Germany flag Germany · Delayed Price · Currency is EUR
19.89
+0.86 (4.52%)
At close: Feb 13, 2026
Market Cap687.00M -70.0%
Revenue (ttm)2.25B +11.8%
Net Income23.35M -79.6%
EPS0.68 -79.6%
Shares Out34.54M
PE Ratio29.42
Forward PE8.57
Dividend0.04 (0.20%)
Ex-Dividend DateJun 6, 2025
Volume374,031
Average Volume409,276
Open19.30
Previous Close19.03
Day's Range19.20 - 19.94
52-Week Range17.60 - 85.25
Beta0.69
RSI31.14
Earnings DateFeb 26, 2026

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery progra... [Read more]

Sector Healthcare
Founded 1864
Employees 13,535
Stock Exchange Deutsche Börse Xetra
Ticker Symbol GXI
Full Company Profile

Financial Performance

In fiscal year 2024, Gerresheimer AG's revenue was 2.04 billion, an increase of 2.28% compared to the previous year's 1.99 billion. Earnings were 109.72 million, a decrease of -5.52%.

Financial Statements

News

Gerresheimer Reschedules 2025 Financials & Starts Centor Sale

Gerresheimer faces delayed accounts, major write-downs and a planned divestment, yet still targets solid growth and margins in 2026 amid ongoing investigations.

5 days ago - Wallstreet:Online

EQS-Adhoc: Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Annual Report / Postponement of the publication/Mergers and Acquisitions / Sale of Business Units Gerresheimer AG reschedules publication of annual and conso...

5 days ago - Wallstreet:Online

EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributi...

4 weeks ago - Wallstreet:Online

Gerresheimer AG Revises Revenue Figures from Bill-and-Hold Deals

Gerresheimer AG revises its 2024 figures after identifying IFRS non-compliance in bill-and-hold revenues, prompting restatements and a modest hit to key earnings metrics.

7 weeks ago - Wallstreet:Online

EQS-Adhoc: Gerresheimer AG: Gerresheimer AG corrects comprehensively revenues from bill-and-hold agreements

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Annual Results Gerresheimer AG: Gerresheimer AG corrects comprehensively revenues from bill-and-hold agreements 22-Dec-2025 / 16:28 CET/CEST Disclosure of an...

7 weeks ago - Wallstreet:Online

Pharmaceutical Packaging Market worth $364.11 billion by 2030 at 15.8%, says MarketsandMarkets™

Delray Beach, FL, Nov. 24, 2025 (GLOBE NEWSWIRE) -- In terms of value, the Pharmaceutical Packaging Market size projected to reach USD 364.11 billion by 2030 from USD 174.85 billion in 2025, at a CAGR...

2 months ago - Benzinga

EQS-News: Gerresheimer AG: Change in the Supervisory Board

EQS-News: Gerresheimer AG / Key word(s): Personnel Gerresheimer AG: Change in the Supervisory Board 20.11.2025 / 13:18 CET/CEST The issuer is solely responsible for the content of this announcement. G...

3 months ago - Wallstreet:Online

EQS-News: Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets

EQS-News: Gerresheimer AG / Key word(s): Sustainability Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets 18.11.2025 / 10:02 CET/CEST The issuer is solely responsible for ...

3 months ago - Wallstreet:Online

EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Gerresheimer AG Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributi...

3 months ago - Wallstreet:Online

Q2 2025 Gerresheimer AG Earnings Call Transcript

Q2 2025 Gerresheimer AG Earnings Call Transcript

3 months ago - GuruFocus

Gerresheimer Appoints Uwe Röhrhoff As Interim CEO, Succeeding Dietmar Siemssen

(RTTNews) - Gerresheimer AG on Tuesday said it has appointed Uwe Röhrhoff as the interim CEO of the Management Board, effective November 1, 2025.

3 months ago - Nasdaq

Gerresheimer appoints Uwe Röhrhoff as new interim CEO

Medical equipment maker Gerresheimer said on Tuesday it had appointed Uwe Röhrhoff as interim CEO, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO by mutual agreeme...

3 months ago - Reuters

EQS-News: Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen

EQS-News: Gerresheimer AG / Key word(s): Personnel Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen 28.10.2025 / 16:10 CET/CEST The issuer is solely responsible for the conten...

3 months ago - Wallstreet:Online

EQS-Adhoc: Gerresheimer AG: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Personnel/Strategic Company Decision Gerresheimer AG: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen 28-Oct-2025 / 16:02 CET/CEST Disclosure of ...

3 months ago - Wallstreet:Online

Gerresheimer finds 2024 revenue-recognition issues after external probe

Medical equipment maker Gerresheimer said it has obtained the initial findings from an investigation by an external law firm into the recognition of revenue and profit from bill-and-hold agreements in...

4 months ago - Reuters

Gerresheimer AG Probed for 2024 Revenue Practices

As Gerresheimer AG navigates this financial investigation, the stakes are high, and the commitment to transparency is unwavering. Jetzt den vollständigen Artikel lesen

4 months ago - Wallstreet:Online

EQS-Adhoc: Gerresheimer AG: Initial findings of an external independent investigation into revenue recognition from bill-and-hold agreements in the 2024 financial year

EQS-Ad-hoc: Gerresheimer AG / Key word(s): Legal Matter Gerresheimer AG: Initial findings of an external independent investigation into revenue recognition from bill-and-hold agreements in the 2024 fi...

4 months ago - Wallstreet:Online

EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

EQS Preliminary announcement financial reports: Gerresheimer AG / Preliminary announcement on the disclosure of financial statements Gerresheimer AG: Preliminary announcement of the publication of qua...

4 months ago - Wallstreet:Online

EQS-AFR: Gerresheimer AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Gerresheimer AG / Preliminary announcement on the disclosure of financial statements Gerresheimer AG: Preliminary announcement of the publication of fin...

4 months ago - Wallstreet:Online

EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 14.10.2025 / 08:14 CET/CEST The issuer is solely responsi...

4 months ago - Wallstreet:Online

EQS-News: Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix ONYU*

EQS-News: Gerresheimer AG / Key word(s): Regulatory Approval Gerresheimer: FDA grants Approval of SQ Innovation’s Lasix ONYU* 13.10.2025 / 10:00 CET/CEST The issuer is solely responsible for the conte...

4 months ago - Wallstreet:Online

Gerresheimer AG (GRRMF) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...

Gerresheimer AG (GRRMF) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives

4 months ago - GuruFocus

Q3 2025 Gerresheimer AG Earnings Call Transcript

Q3 2025 Gerresheimer AG Earnings Call Transcript

4 months ago - GuruFocus

Gerresheimer AG (GRRMY) Q3 2025 Earnings Call Transcript

Gerresheimer AG (OTCPK:GRRMY) Q3 2025 Earnings Call October 9, 2025 2:30 AM EDT Company Participants Guido Pickert - Head of Investor Relations Dietmar Siemssen - CEO, Chairman of the Management Board...

4 months ago - Seeking Alpha

Gerresheimer's shares fall 11% after another outlook cut

Shares in Gerresheimer fell 11% on Thursday, a day after the German packaging and medical equipment maker cut its 2025 guidance for the third time this year.

4 months ago - Reuters